Description
Tesamorelin is a stabilized synthetic analog of growth hormone-releasing hormone (GHRH), engineered with structural modifications that improve its resistance to enzymatic breakdown. In laboratory settings it functions as a reference agonist of the GHRH receptor, valued for probing somatotropic axis signaling.
Experimental work with Tesamorelin spans cell-culture and murine investigations into pulsatile growth hormone output, downstream IGF-1 signaling, and lipid and visceral adipose metabolism. Its enhanced stability profile lends itself to extended time-course study designs examining GHRH-pathway activity.
Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.






Reviews
There are no reviews yet.